These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12035756)

  • 21. Anti-HIV agents. Why are drug holidays dangerous?
    TreatmentUpdate; 2009 Jan; 21(1):6-7. PubMed ID: 19248285
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV-1 therapeutic vaccines.
    Kinloch-de Loes S; Autran B
    J Infect; 2002 Apr; 44(3):152-9. PubMed ID: 12099741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pill burden key to doing well.
    AIDS Patient Care STDS; 2000 May; 14(5):281-2. PubMed ID: 10833816
    [No Abstract]   [Full Text] [Related]  

  • 24. Sloppy treatment impulses.
    Fallon SJ
    Posit Aware; 2001; 12(5):38-9. PubMed ID: 11688486
    [No Abstract]   [Full Text] [Related]  

  • 25. Structured treatment interruptions and treatment intensification.
    Vella S
    AIDS Clin Care; 2000 Jul; 12(7):55-7, 62. PubMed ID: 12170956
    [No Abstract]   [Full Text] [Related]  

  • 26. Medicare D has big impact on HIV treatment interruptions. Decreased access to meds, six-fold increase in interruptions.
    AIDS Alert; 2008 Nov; 23(11):121-3. PubMed ID: 19043865
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment interruption consequences unknown.
    Strain W
    Posit Living; 1999 Sep; 8(8):6, 15. PubMed ID: 12510631
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA notifications. Pediatric HIV infection guidelines for use of ARTs are revised.
    AIDS Alert; 2008 Apr; 23(4):46-7. PubMed ID: 19255980
    [No Abstract]   [Full Text] [Related]  

  • 29. Guideline watch. HIV treatment guidelines updated.
    Zuger A
    AIDS Clin Care; 2006 Jun; 18(6):57. PubMed ID: 16791954
    [No Abstract]   [Full Text] [Related]  

  • 30. Top stories of 2008. Earlier HIV treatment is gaining momentum.
    Henry K
    AIDS Clin Care; 2009 Jan; 21(1):1-2. PubMed ID: 19219955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New horizons in the treatment of HIV.
    HIV Inside; 2003; 5(3):1, 3-8, 11-2. PubMed ID: 14974422
    [No Abstract]   [Full Text] [Related]  

  • 32. [HIV management requires strategic planning. Optimal sequencing of protease inhibitors].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():21-4. PubMed ID: 11373770
    [No Abstract]   [Full Text] [Related]  

  • 33. Structured treatment interruptions in chronic HIV management: where next?
    Pai NP; Klein MB
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):909-12. PubMed ID: 17181404
    [No Abstract]   [Full Text] [Related]  

  • 34. The state of the science of HIV treatment approaches.
    Follansbee SE
    Focus; 2007 Jan; 22(1):1-5. PubMed ID: 17526105
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy planning. It depends on the proper administration series].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():82-5. PubMed ID: 10863322
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV treatment series. Part 4 of 4. Decisions, decisions--starting or switching anti-HIV therapy.
    McGuire S
    Posit Aware; 2003; 14(3):31-6. PubMed ID: 12866490
    [No Abstract]   [Full Text] [Related]  

  • 37. Intermittent therapy for the treatment of chronic HIV infection.
    Ananworanich J; Hirschel B
    AIDS; 2007 Jan; 21(2):123-34. PubMed ID: 17197802
    [No Abstract]   [Full Text] [Related]  

  • 38. Interruptions may be beneficial.
    AIDS Patient Care STDS; 2002 Oct; 16(10):512. PubMed ID: 12442736
    [No Abstract]   [Full Text] [Related]  

  • 39. Dutch study finds treatment interruptions safe for some.
    Proj Inf Perspect; 2007 Oct; (44):24. PubMed ID: 18046836
    [No Abstract]   [Full Text] [Related]  

  • 40. Strategies for third line therapy.
    Proj Inf Perspect; 2002 Mar; (34):8-9. PubMed ID: 12038303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.